Mission — The Global Leukodystrophy Initiative

Home Contact

Participate

About GLIA-CTN Leadership Core Groups Investigators Locations Projects

Advocacy Partners Research Partners

2018 H-ABC Family Conference 2022 GLIA Scientific Meeting and Advocacy Workshop 2025 GLIA Scientific Meeting and Advocacy Workshop 2026 TUBB4A Virtual Family Conference

Project Data Funding Opportunities

Home Clinical Trials Network About GLIA-CTN Leadership Core Groups Investigators Locations Projects Consortium Advocacy Partners Research Partners Events 2018 H-ABC Family Conference 2022 GLIA Scientific Meeting and Advocacy Workshop 2025 GLIA Scientific Meeting and Advocacy Workshop 2026 TUBB4A Virtual Family Conference Resources Project Data Funding Opportunities Contact

The Global Leukodystrophy Initiative

Scroll

The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). GLIA-CTN is funded under grant number U54NS115052 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). The content of this website is solely the responsibility of the GLIA-CTN Administrative Core at the Children’s Hospital of Philadelphia, and does not necessarily represent the official views of the NIH.

© 2022 Global Leukodystrophy Initiative (GLIA)

GLIA-CTN Administrative Hub
3615 Civic Center Blvd. ARC516H
Philadelphia, PA 19104

Powered by:
Squarespace

GLIA-CTN Info

Mission
Leadership
Investigators
Projects
Sites

GLIA INFO

Advocacy Partners
Research Partners

Sign up to receive news and updates.

First Name

Last Name

Email Address

Thank you!